Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

被引：14
|
作者：
Castilla, J. [1 ,2 ]
Martinez-Baz, I. [1 ,2 ]
Navascues, A. [3 ]
Fernandez-Alonso, M. [4 ]
Reina, G. [4 ]
Guevara, M. [1 ,2 ]
Chamorro, J. [3 ]
Ortega, M. T. [5 ]
Albeniz, E. [6 ]
Pozo, F. [7 ]
Ezpeleta, C. [3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Valencia, Spain
[3] Complejo Hosp Navarra, Pamplona, Spain
[4] Univ Navarra Clin, Pamplona, Spain
[5] Hosp Reina Sofia, Tudela, Spain
[6] Direcc Atenc Primaria, Navarre Hlth Serv, Pamplona, Spain
[7] WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Inst Salud Carlos III, Majadahonda, Spain
来源：
EUROSURVEILLANCE | 2014年 / 19卷 / 06期
关键词：
D O I：
10.2807/1560-7917.ES2014.19.6.20700
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [1] Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season
    Castilla, J.
    Navascues, A.
    Fernandez-Alonso, M.
    Reina, G.
    Albeniz, E.
    Pozo, F.
    Alvarez, N.
    Martinez-Baz, I.
    Guevara, M.
    Garcia-Cenoz, M.
    Irisarri, F.
    Casado, I.
    Ezpeleta, C.
    EUROSURVEILLANCE, 2016, 21 (22): : 10 - 19
  • [2] Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022-2023
    Martinez-Baz, Ivan
    Fernandez-Huerta, Miguel
    Navascues, Ana
    Pozo, Francisco
    Trobajo-Sanmartin, Camino
    Casado, Itziar
    Echeverria, Aitziber
    Ezpeleta, Carmen
    Castilla, Jesus
    VACCINES, 2023, 11 (09)
  • [3] Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results
    Pebody, R.
    Warburton, F.
    Ellis, J.
    Andrews, N.
    Potts, A.
    Cottrell, S.
    Johnston, J.
    Reynolds, A.
    Gunson, R.
    Thompson, C.
    Galiano, M.
    Robertson, C.
    Mullett, D.
    Gallagher, N.
    Sinnathamby, M.
    Yonova, I.
    Moore, C.
    McMenamin, J.
    de Lusignan, S.
    Zambon, M.
    EUROSURVEILLANCE, 2016, 21 (13) : 31 - 38
  • [4] Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis
    Castilla, J.
    Martinez-Baz, I.
    Martinez-Artola, V.
    Fernandez-Alonso, M.
    Reina, G.
    Guevara, M.
    Garcia Cenoz, M.
    Elia, F.
    Alvarez, N.
    Barricarte, A.
    Ezpeleta, C.
    EUROSURVEILLANCE, 2013, 18 (07): : 6 - 11
  • [5] Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results
    Pebody, R. G.
    Warburton, F.
    Ellis, J.
    Andrews, N.
    Thompson, C.
    von Wissmann, B.
    Green, H. K.
    Cottrell, S.
    Johnston, J.
    de Lusignan, S.
    Moore, C.
    Gunson, R.
    Robertson, C.
    McMenamin, J.
    Zambon, M.
    EUROSURVEILLANCE, 2015, 20 (05) : 6 - 12
  • [6] Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13
    McMenamin, J.
    Andrews, N.
    Robertson, C.
    Fleming, D. M.
    Durnall, H.
    von Wissmann, B.
    Ellis, J.
    Lackenby, A.
    Cottrell, S.
    Smyth, B.
    Zambon, M.
    Moore, C.
    Watson, J. M.
    Pebody, R. G.
    EUROSURVEILLANCE, 2013, 18 (05): : 2 - 6
  • [7] Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain
    Cenoz, Manuel Garcia
    Martinez-Artola, Victor
    Guevara, Marcela
    Ezpeleta, Carmen
    Barricarte, Aurelio
    Castilla, Jesus
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 1172 - 1176
  • [8] Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Adults, 2011-2012 Influenza Season
    Talbot, H. Keipp
    Zhu, Yuwei
    Chen, Qingxia
    Williams, John V.
    Thompson, Mark G.
    Griffin, Marie R.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1774 - 1777
  • [9] Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults
    Hughes, Kailey
    Middleton, Donald B.
    Nowalk, Mary Patricia
    Balasubramani, Goundappa K.
    Martin, Emily T.
    Gaglani, Manjusha
    Talbot, H. Keipp
    Patel, Manish M.
    Ferdinands, Jill M.
    Zimmerman, Richard K.
    Silveira, Fernanda P.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4353 - E4360
  • [10] Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
    Castilla, Jesus
    Godoy, Pere
    Dominguez, Angela
    Martinez-Baz, Ivan
    Astray, Jenaro
    Martin, Vicente
    Delgado-Rodriguez, Miguel
    Baricot, Maretva
    Soldevila, Nuria
    Maria Mayoral, Jose
    Maria Quintana, Jose
    Carlos Galan, Juan
    Castro, Ady
    Gonzalez-Candelas, Fernando
    Garin, Olatz
    Saez, Marc
    Tamames, Sonia
    Pumarola, Tomas
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) : 167 - 175
12345